肌肉鬆弛药物市场 - 按药物类型（骨骼肌鬆弛药物）、剂型（片剂、胶囊）、应用（肌肉痉挛和止痛）、给药途径（口服）、配销通路（医院药房）、2023年全球预测- 2032

2023年至2032年，全球肌肉鬆弛药物市场将以6.4%的复合年增长率成长。人口老化导致肌肉骨骼疾病和病症的发生率增加，推动肌肉鬆弛药物业务的发展。

此外，压力水平的上升和久坐的生活方式导致肌肉相关问题激增，进一步促进了该行业的成长。人们越来越认识到这些药物在疼痛管理方面的功效，以及将治疗应用扩展到肌肉骨骼疾病之外，将推动业务成长。

新颖配方的引入和对非成瘾替代品的追求也有望推动市场扩张。 2022 年 6 月，Amneal Pharmaceuticals 推出了 LYVISPAH，这是一种含有巴氯芬的创新口服颗粒药物，已获得美国 FDA 批准，用于治疗与多发性硬化症和各种脊髓疾病等疾病相关的痉挛。

市场根据药物类型、剂型、应用、给药途径、配销通路和地区进行分类。

根据药物类型，到2032 年，脸部肌肉鬆弛药物领域的复合年增长率将达到5.7%，这主要得益于对非侵入性整容手术的需求不断增长、对美容的日益偏好以及面部年轻化技术的进步。此外，寻求脸部肌肉放鬆疗程的老化人口不断增加将促进该领域的成长。

在易于给药、更快起效和改善患者依从性等因素的推动下，液体剂型部分在分析期间将呈现 6.1% 的复合年增长率。液体製剂因其方便和更快的治疗效果而受到优选。

到 2032 年，手术应用领域的复合年增长率将达到 5.7%。外科手术（包括微创手术）的增加将推动手术用肌肉鬆弛药物的业务。外科医生依靠肌肉鬆弛剂来提高手术精度和患者安全，从而推动市场扩张。

从地区来看，在人口老龄化、肌肉骨骼疾病患病率上升、医疗基础设施不断完善以及对治疗选择意识不断增强的推动下，亚太地区肌肉鬆弛药物行业预计在2023 年至2032 年期间将以7.3% 的复合年增长率成长。此外，製药创新和扩大医疗保健服务范围将促进该地区的业务成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：肌肉鬆弛药市场洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 老年人口增加与慢性病伴
    • 肌肉骨骼疾病的盛行率不断增加
    • 药物开发不断进步
  • 产业陷阱与挑战
    • 与肌肉鬆弛剂相关的副作用
    • 严格的监理规范
• 成长潜力分析
• COVID-19 影响分析
• 监管环境
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：肌肉鬆弛药物市场估计与预测：按药物类型，2018 - 2032

• 主要动向：依药物类型
• 骨骼肌鬆弛药
• 神经肌肉阻断剂
• 脸部肌肉鬆弛药

第 6 章：肌肉鬆弛药物市场估计与预测：按剂型，2018 - 2032

• 主要动力方向：按剂型
• 药片
• 胶囊
• 液体
• 凝胶、软膏和喷雾剂

第 7 章：肌肉鬆弛药物市场估计与预测：按应用，2018 - 2032

• 主要动向：按应用
• 缓解肌肉痉挛和疼痛
• 肌肉骨骼疾病
• 手术
• 其他应用

第 8 章：肌肉鬆弛药物市场估计与预测：按给药途径，2018 年 - 2032 年

• 主要动向：按给药途径
• 口服
• 注射用
• 专题

第 9 章：肌肉鬆弛药物市场估计与预测：按配销通路，2018 - 2032

• 主要动向：按配销通路
• 医院药房
• 专业及零售药房
• 网路药房

第 10 章：肌肉鬆弛药物市场估计与预测：按地区，2018 - 2032

• 主要动向：按地区
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 中东和非洲其他地区

第 11 章：公司简介

• Amneal Pharmaceuticals LLC
• Ipsen Biopharmaceuticals, Inc.
• Merz Pharmaceuticals, LLC.
• Mylan (Viatris)
• Sanofi
• Pfizer Inc
• Novartis AG
• Teva Pharmaceuticals Industries Ltd, Inc.
• Vertical Pharmaceuticals
• Sun Pharmaceutical Industries Ltd.
• SteriMax Inc
• Par Pharmaceutical
• Abbott Laboratories
• F. Hoffmann-La Roche AG

The global muscle relaxant drugs market will grow at a 6.4% CAGR from 2023 to 2032. An aging population is experiencing an increased incidence of musculoskeletal disorders and conditions, driving the business for muscle relaxant medications.

Additionally, rising stress levels and sedentary lifestyles contribute to a surge in muscle-related issues, further boosting the industry's growth. The growing awareness of the efficacy of these drugs in pain management and the expansion of therapeutic applications beyond just musculoskeletal disorders will drive business growth.

The introduction of novel formulations and the pursuit of non-addictive alternatives are also anticipated to fuel market expansion. In June 2022, Amneal Pharmaceuticals introduced LYVISPAH, an innovative oral granules medication containing baclofen, which has received approval from the USFDA for the treatment of spasticity associated with conditions such as multiple sclerosis and various spinal cord disorders.

The market is categorized based on drug type, dosage form, application, route of administration, distribution channel, and region.

Based on drug type, the facial muscle relaxant drug segment will record a 5.7% CAGR through 2032, driven by the rising demand for non-invasive cosmetic procedures, growing preference for aesthetic enhancements, and advancements in facial rejuvenation technologies. Moreover, rising aging population seeking facial muscle relaxation treatments will foster growth in the segment.

The liquid dosage form segment will exhibit a 6.1% CAGR during the analysis period, driven by factors such as ease of administration, faster onset of action, and improved patient compliance. Liquid formulations are preferred for their convenience and quicker therapeutic effects.

The surgery application segment will reflect a 5.7% CAGR through 2032. Increasing surgical procedures, including minimally invasive surgeries will drive the business of muscle relaxant drugs for surgery. Surgeons rely on muscle relaxants to enhance surgical precision and patient safety, driving market expansion.

Regionally, the Asia Pacific muscle relaxant drugs industry is anticipated to grow at a 7.3% CAGR during 2023-2032, driven by the aging population, rising prevalence of musculoskeletal disorders, increasing healthcare infrastructure, and a growing awareness of treatment options. Moreover, pharmaceutical innovation and expanding healthcare access will augment business growth in the region.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Covid-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Global muscle relaxant drugs market 360 degree synopsis, 2018 - 2032 (USD Million)
  • 2.1.1 Business trends
  • 2.1.2 Region trends
  • 2.1.3 Drug type trends
  • 2.1.4 Dosage form trends
  • 2.1.5 Application trends
  • 2.1.6 Route of administration trends
  • 2.1.7 Distribution channel trends

Chapter 3 Muscle Relaxant Drugs Market Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing geriatric population coupled with chronic diseases
    • 3.2.1.2 Increasing prevalence of musculoskeletal disorders
    • 3.2.1.3 Growing advancement in drug development
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Side-effects associated with muscle relaxants
    • 3.2.2.2 Strict regulatory norms
• 3.3 Growth potential analysis
  • 3.3.1 By drug type
  • 3.3.2 By dosage form
  • 3.3.3 By application
  • 3.3.4 By route of administration
  • 3.3.5 By distribution channel
• 3.4 COVID-19 impact analysis
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive analysis of major market players, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Strategic dashboard, 2022

Chapter 5 Muscle Relaxant Drugs Market Estimates and Forecast, By Drug Type, 2018 - 2032 (USD Million)

• 5.1 Key trends, by drug type
• 5.2 Skeletal muscle relaxant drugs
• 5.3 Neuromuscular blocking agents
• 5.4 Facial muscle relaxant drugs

Chapter 6 Muscle Relaxant Drugs Market Estimates and Forecast, By Dosage Form, 2018 - 2032 (USD Million)

• 6.1 Key trends, by dosage form
• 6.2 Tablet
• 6.3 Capsule
• 6.4 Liquid
• 6.5 Gel, ointments & sprays

Chapter 7 Muscle Relaxant Drugs Market Estimates and Forecast, By Application, 2018 - 2032 (USD Million)

• 7.1 Key trends, by application
• 7.2 Muscle spasm & pain relief
• 7.3 Musculoskeletal disorders
• 7.4 Surgery
• 7.5 Other applications

Chapter 8 Muscle Relaxant Drugs Market Estimates and Forecast, By Route of Administration, 2018 - 2032 (USD Million)

• 8.1 Key trends, by route of administration
• 8.2 Oral
• 8.3 Parenteral
• 8.4 Topical

Chapter 9 Muscle Relaxant Drugs Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 (USD Million)

• 9.1 Key trends, by distribution channel
• 9.2 Hospital pharmacy
• 9.3 Specialty & Retail pharmacy
• 9.4 Online pharmacy

Chapter 10 Muscle Relaxant Drugs Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

• 10.1 Key trends, by region
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 Rest of Asia Pacific
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Rest of Latin America
• 10.6 Middle East & Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 Rest of Middle East & Africa

Chapter 11 Company Profiles

• 11.1 Amneal Pharmaceuticals LLC
• 11.2 Ipsen Biopharmaceuticals, Inc.
• 11.3 Merz Pharmaceuticals, LLC.
• 11.4 Mylan (Viatris)
• 11.5 Sanofi
• 11.6 Pfizer Inc
• 11.7 Novartis AG
• 11.8 Teva Pharmaceuticals Industries Ltd, Inc.
• 11.9 Vertical Pharmaceuticals
• 11.10 Sun Pharmaceutical Industries Ltd.
• 11.11 SteriMax Inc
• 11.12 Par Pharmaceutical
• 11.13 Abbott Laboratories
• 11.14 F. Hoffmann-La Roche AG

Data Tables

• TABLE 1 Product mapping
• TABLE 2 Market revenue, by drug type (2022)
• TABLE 3 Market revenue, by dosage form (2022)
• TABLE 4 Market revenue, by application (2022)
• TABLE 5 Market revenue, by route of administration (2022)
• TABLE 6 Market revenue, by distribution channel (2022)
• TABLE 7 Market share, by region (2022)
• TABLE 8 Global muscle relaxant drugs market size, by region, 2018 - 2022 (USD Million)
• TABLE 9 Global muscle relaxant drugs market size, by region, 2023 - 2032 (USD Million)
• TABLE 10 Global muscle relaxant drugs market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 11 Global muscle relaxant drugs market size, by drug type, 2023 - 2032 (USD Million)
• TABLE 12 Global muscle relaxant drugs market size, by dosage form, 2018 - 2022 (USD Million)
• TABLE 13 Global muscle relaxant drugs market size, by dosage form, 2023 - 2032 (USD Million)
• TABLE 14 Global muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 15 Global muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 16 Global muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 17 Global muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 18 Global muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 19 Global muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 20 Industry impact forces
• TABLE 21 Skeletal muscle relaxant drugs market size, 2018-2022 (USD Million)
• TABLE 22 Skeletal muscle relaxant drugs market size, 2023-2032 (USD Million)
• TABLE 23 Neuromuscular blocking agents market size, 2018-2022 (USD Million)
• TABLE 24 Neuromuscular blocking agents market size, 2023-2032 (USD Million)
• TABLE 25 Facial muscle relaxant drugs market size, 2018-2022 (USD Million)
• TABLE 26 Facial muscle relaxant drugs market size, 2023-2032 (USD Million)
• TABLE 27 Tablet market size, 2018-2022 (USD Million)
• TABLE 28 Tablet market size, 2023-2032 (USD Million)
• TABLE 29 Capsule market size, 2018-2022 (USD Million)
• TABLE 30 Capsule market size, 2023-2032 (USD Million)
• TABLE 31 Liquid market size, 2018-2022 (USD Million)
• TABLE 32 Liquid market size, 2023-2032 (USD Million)
• TABLE 33 Gel, ointments & sprays market size, 2018-2022 (USD Million)
• TABLE 34 Gel, ointments & sprays market size, 2023-2032 (USD Million)
• TABLE 35 Muscle spasm & pain relief market size, 2018-2022 (USD Million)
• TABLE 36 Muscle spasm & pain relief market size, 2023-2032 (USD Million)
• TABLE 37 Musculoskeletal disorders market size, 2018-2022 (USD Million)
• TABLE 38 Musculoskeletal disorders market size, 2023-2032 (USD Million)
• TABLE 39 Surgery market size, 2018-2022 (USD Million)
• TABLE 40 Surgery market size, 2023-2032 (USD Million)
• TABLE 41 Other applications market size, 2018-2022 (USD Million)
• TABLE 42 Other applications market size, 2023-2032 (USD Million)
• TABLE 43 Oral market size, 2018-2022 (USD Million)
• TABLE 44 Oral market size, 2023-2032 (USD Million)
• TABLE 45 Parenteral market size, 2018-2022 (USD Million)
• TABLE 46 Parenteral market size, 2023-2032 (USD Million)
• TABLE 47 Topical market size, 2018-2022 (USD Million)
• TABLE 48 Topical market size, 2023-2032 (USD Million)
• TABLE 49 Hospital pharmacy market size, 2018-2022 (USD Million)
• TABLE 50 Hospital pharmacy market size, 2023-2032 (USD Million)
• TABLE 51 Specialty & Retail pharmacy market size, 2018-2022 (USD Million)
• TABLE 52 Specialty & Retail pharmacy market size, 2023-2032 (USD Million)
• TABLE 53 Online pharmacy market size, 2018-2022 (USD Million)
• TABLE 54 Online pharmacy market size, 2023-2032 (USD Million)
• TABLE 55 North America muscle relaxant drugs market size, by country, 2018-2022 (USD Million)
• TABLE 56 North America muscle relaxant drugs market size, by country, 2023-2032 (USD Million)
• TABLE 57 North America muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 58 North America muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 59 North America muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 60 North America muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 61 North America muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 62 North America muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 63 North America muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 64 North America muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 65 North America muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 66 North America muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 67 U.S. muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 68 U.S. muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 69 U.S. muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 70 U.S. muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 71 U.S. muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 72 U.S. muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 73 U.S. muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 74 U.S. muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 75 U.S. muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 76 U.S. muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 77 Canada muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 78 Canada muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 79 Canada muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 80 Canada muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 81 Canada muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 82 Canada muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 83 Canada muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 84 Canada muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 85 Canada muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 86 Canada muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 87 Europe muscle relaxant drugs market size, by country, 2018-2022 (USD Million)
• TABLE 88 Europe muscle relaxant drugs market size, by country, 2023-2032 (USD Million)
• TABLE 89 Europe muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 90 Europe muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 91 Europe muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 92 Europe muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 93 Europe muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 94 Europe muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 95 Europe muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 96 Europe muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 97 Europe muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 98 Europe muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 99 Germany muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 100 Germany muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 101 Germany muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 102 Germany muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 103 Germany muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 104 Germany muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 105 Germany muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 106 Germany muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 107 Germany muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 108 Germany muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 109 UK muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 110 UK muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 111 UK muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 112 UK muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 113 UK muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 114 UK muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 115 UK muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 116 UK muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 117 UK muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 118 UK muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 119 France muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 120 France muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 121 France muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 122 France muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 123 France muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 124 France muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 125 France muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 126 France muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 127 France muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 128 France muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 129 Spain muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 130 Spain muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 131 Spain muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 132 Spain muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 133 Spain muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 134 Spain muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 135 Spain muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 136 Spain muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 137 Spain muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 138 Spain muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 139 Italy muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 140 Italy muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 141 Italy muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 142 Italy muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 143 Italy muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 144 Italy muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 145 Italy muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 146 Italy muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 147 Italy muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 148 Italy muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 149 Rest of Europe muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 150 Rest of Europe muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 151 Rest of Europe muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 152 Rest of Europe muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 153 Rest of Europe muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 154 Rest of Europe muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 155 Rest of Europe muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 156 Rest of Europe muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 157 Rest of Europe muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 158 Rest of Europe muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 159 Asia Pacific muscle relaxant drugs market size, by country, 2018-2022 (USD Million)
• TABLE 160 Asia Pacific muscle relaxant drugs market size, by country, 2023-2032 (USD Million)
• TABLE 161 Asia Pacific muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 162 Asia Pacific muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 163 Asia Pacific muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 164 Asia Pacific muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 165 Asia Pacific muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 166 Asia Pacific muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 167 Asia Pacific muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 168 Asia Pacific muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 169 Asia Pacific muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 170 Asia Pacific muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 171 China muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 172 China muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 173 China muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 174 China muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 175 China muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 176 China muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 177 China muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 178 China muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 179 China muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 180 China muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 181 Japan muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 182 Japan muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 183 Japan muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 184 Japan muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 185 Japan muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 186 Japan muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 187 Japan muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 188 Japan muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 189 Japan muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 190 Japan muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 191 India muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 192 India muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 193 India muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 194 India muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 195 India muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 196 India muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 197 India muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 198 India muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 199 India muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 200 India muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 201 Australia muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 202 Australia muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 203 Australia muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 204 Australia muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 205 Australia muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 206 Australia muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 207 Australia muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 208 Australia muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 209 Australia muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 210 Australia muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 211 Rest of Asia Pacific muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 212 Rest of Asia Pacific muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 213 Rest of Asia Pacific muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 214 Rest of Asia Pacific muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 215 Rest of Asia Pacific muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 216 Rest of Asia Pacific muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 217 Rest of Asia Pacific muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 218 Rest of Asia Pacific muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 219 Rest of Asia Pacific muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 220 Rest of Asia Pacific muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 221 Latin America muscle relaxant drugs market size, by country, 2018-2022 (USD Million)
• TABLE 222 Latin America muscle relaxant drugs market size, by country, 2023-2032 (USD Million)
• TABLE 223 Latin America muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 224 Latin America muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 225 Latin America muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 226 Latin America muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 227 Latin America muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 228 Latin America muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 229 Latin America muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 230 Latin America muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 231 Latin America muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 232 Latin America muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 233 Brazil muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 234 Brazil muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 235 Brazil muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 236 Brazil muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 237 Brazil muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 238 Brazil muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 239 Brazil muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 240 Brazil muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 241 Brazil muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 242 Brazil muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 243 Mexico muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 244 Mexico muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 245 Mexico muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 246 Mexico muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 247 Mexico muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 248 Mexico muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 249 Mexico muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 250 Mexico muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 251 Mexico muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 252 Mexico muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 253 Rest of Latin America muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 254 Rest of Latin America muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 255 Rest of Latin America muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 256 Rest of Latin America muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 257 Rest of Latin America muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 258 Rest of Latin America muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 259 Rest of Latin America muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 260 Rest of Latin America muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 261 Rest of Latin America muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 262 Rest of Latin America muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 263 Middle East & Africa muscle relaxant drugs market size, by country, 2018-2022 (USD Million)
• TABLE 264 Middle East & Africa muscle relaxant drugs market size, by country, 2023-2032 (USD Million)
• TABLE 265 Middle East & Africa muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 266 Middle East & Africa muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 267 Middle East & Africa muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 268 Middle East & Africa muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 269 Middle East & Africa muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 270 Middle East & Africa muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 271 Middle East & Africa muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 272 Middle East & Africa muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 273 Middle East & Africa muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 274 Middle East & Africa muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 275 South Africa muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 276 South Africa muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 277 South Africa muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 278 South Africa muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 279 South Africa muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 280 South Africa muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 281 South Africa muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 282 South Africa muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 283 South Africa muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 284 South Africa muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 285 Saudi Arabia muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 286 Saudi Arabia muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 287 Saudi Arabia muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 288 Saudi Arabia muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 289 Saudi Arabia muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 290 Saudi Arabia muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 291 Saudi Arabia muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 292 Saudi Arabia muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 293 Saudi Arabia muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 294 Saudi Arabia muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 295 Rest of Middle East & Africa muscle relaxant drugs market size, by drug type, 2018-2022 (USD Million)
• TABLE 296 Rest of Middle East & Africa muscle relaxant drugs market size, by drug type, 2023-2032 (USD Million)
• TABLE 297 Rest of Middle East & Africa muscle relaxant drugs market size, by dosage form, 2018-2022 (USD Million)
• TABLE 298 Rest of Middle East & Africa muscle relaxant drugs market size, by dosage form, 2023-2032 (USD Million)
• TABLE 299 Rest of Middle East & Africa muscle relaxant drugs market size, by application, 2018-2022 (USD Million)
• TABLE 300 Rest of Middle East & Africa muscle relaxant drugs market size, by application, 2023-2032 (USD Million)
• TABLE 301 Rest of Middle East & Africa muscle relaxant drugs market size, by route of administration, 2018-2022 (USD Million)
• TABLE 302 Rest of Middle East & Africa muscle relaxant drugs market size, by route of administration, 2023-2032 (USD Million)
• TABLE 303 Rest of Middle East & Africa muscle relaxant drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 304 Rest of Middle East & Africa muscle relaxant drugs market size, by distribution channel, 2023-2032 (USD Million)

Charts & Figures

• FIG 1 Industry segmentation
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Muscle relaxant drugs industry 360 degree synopsis, 2018 - 2032
• FIG 7 Industry ecosystem analysis
• FIG 8 Growth potential analysis, by drug type
• FIG 9 Growth potential analysis, by dosage form
• FIG 10 Growth potential analysis, by application
• FIG 11 Growth potential analysis, by route of administration
• FIG 12 Growth potential analysis, by distribution channel
• FIG 13 Porter's analysis
• FIG 14 PESTEL analysis
• FIG 15 Company matrix analysis, 202
• FIG 16 Competitive analysis of major market players, 2022
• FIG 17 Competitive positioning matrix
• FIG 18 Strategic dashboard